BioCentury
ARTICLE | Clinical News

Anzemet dolasetron regulatory update

January 3, 2011 8:00 AM UTC

FDA issued a drug safety communication warning that sanofi's IV Anzemet dolasetron should not be used to prevent nausea and vomiting associated with cancer chemotherapy (CINV) after data demonstrated ...